Advertisement

Topics

Demetrix Secures $50 Million In Series A Funding To Provide Cannabinoids To Pharmaceutical, Supplement, And Consumer Product Companies

09:43 EDT 12 Jul 2019 | Synbiobeta

Funding Round led by Tuatara Capital with Continued Participation by Horizons Ventures EMERYVILLE, Calif., July 11, 2019 /PRNewswire/ — Today, Demetrix Inc., a biotechnology company focused on the production of cannabinoids, announced that it has secured $50 million in Series A funding. The round was led by Tuatara Capital with participation from existing investor Horizons Ventures. […]

The post Demetrix Secures $50 Million In Series A Funding To Provide Cannabinoids To Pharmaceutical, Supplement, And Consumer Product Companies appeared first on SynBioBeta.

Original Article: Demetrix Secures $50 Million In Series A Funding To Provide Cannabinoids To Pharmaceutical, Supplement, And Consumer Product Companies

NEXT ARTICLE

More From BioPortfolio on "Demetrix Secures $50 Million In Series A Funding To Provide Cannabinoids To Pharmaceutical, Supplement, And Consumer Product Companies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...